Valuation: Illumina, Inc.

Market Cap 32.49B 29.14B 26.86B 24.39B 46.16B 3,047B 47.45B 322B 128B 1,632B 122B 119B 5,160B P/E 2026 *
42.5x
P/E 2027 * 36.1x
Enterprise Value 32.41B 29.07B 26.79B 24.33B 46.04B 3,039B 47.33B 321B 128B 1,628B 122B 119B 5,147B EV / Sales 2026 *
7x
EV / Sales 2027 * 6.34x
Free-Float
74.99%
Yield 2026 *
-
Yield 2027 * -
1 day-2.66%
1 week-9.78%
Current month-8.93%
1 month-22.74%
3 months+12.05%
6 months+51.47%
Current year+63.85%
1 week 205
Extreme 205
222.85
1 month 205
Extreme 205
294.2
Current year 112.65
Extreme 112.65
309.34
1 year 112.65
Extreme 112.65
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap. Importance
11/4/26
Corvex Management LP
SellCompany -50,000 0.0331%
11/3/26 Other

Director

0 0.0000%
10/5/26 Tax

Chief Executive Officer

-1,303 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-2.66%-9.78%+76.56%+118.47% 32.49B
-0.48%+2.84%+24.61%+60.16% 266B
+0.42%+2.61%+11.81%+19.85% 166B
-2.28%+2.11%-21.90%+62.18% 156B
+1.54%+2.76%-55.70%-13.30% 64.79B
-0.67%+9.27%+23.70%+61.98% 59.81B
+0.80%-0.95%-0.97%-9.81% 53.3B
-1.27%+1.38%+21.54%+63.99% 50.15B
-0.28%+0.77%+3.31%+85.09% 49.47B
-0.25%+3.40%+26.28%+85.81% 46.72B
Average -0.52%+1.80%+10.92%+53.44% 94B
Weighted average by Cap. -0.52%+2.56%+8.27%+49.32%

Financials

2026 *2027 *
Net sales 4.63B 4.15B 3.83B 3.48B 6.58B 434B 6.76B 45.82B 18.26B 233B 17.38B 17.01B 735B 4.95B 4.44B 4.09B 3.72B 7.04B 465B 7.23B 49.03B 19.53B 249B 18.59B 18.2B 787B
Net income 792M 710M 655M 594M 1.13B 74.25B 1.16B 7.84B 3.12B 39.78B 2.97B 2.91B 126B 914M 820M 756M 686M 1.3B 85.71B 1.33B 9.05B 3.6B 45.92B 3.43B 3.36B 145B
Net Debt -83.57M -74.94M -69.07M -62.72M -119M -7.84B -122M -827M -329M -4.2B -314M -307M -13.27B -1.1B -989M -912M -828M -1.57B -103B -1.61B -10.91B -4.35B -55.4B -4.14B -4.05B -175B
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
26-11-10 $214.91 -2.66% 1,363,481
26-11-09 $220.78 +3.59% 1,863,768
26-11-06 $213.13 +2.47% 2,064,505
26-11-05 $208.00 -8.18% 4,236,753
26-11-04 $226.54 -4.90% 3,036,411
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
214.91USD
Average target price
261.45USD
Spread / Average Target
+21.66%
  1. Stock Market
  2. Stocks
  3. ILMN Stock